Press Release - All

• 18 Jan 2023
  Agilent Included in Just Capital’s 2023 List of Most Just Companies
• 09 Jan 2023
  Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics
• 09 Jan 2023
  Agilent Authorizes $2 Billion Share Repurchase Program
• 06 Jan 2023
  Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications
• 04 Jan 2023
  Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
• 16 Dec 2022
  Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
• 12 Dec 2022
  Agilent Resolution ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung Cancer
• 07 Dec 2022
  Agilent Again Named to Newsweek’s List of America’s Most Responsible Companies
• 05 Dec 2022
  Agilent Opens Customer Experience Center Highlighting Genomics and Diagnostics Solutions
• 30 Nov 2022
  Agilent Attains ‘Angel’ Level Sponsorship with My Green Lab